Wellington Management Group LLP Orchard Therapeutics PLC Transaction History

Wellington Management Group LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.24 - $4.29 $184,999 - $354,306	-82,589 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$4.39 - $7.23 $24,096 - $39,685	-5,489 Reduced 6.23%	82,589 $363,000
Q1 2021 May 17, 2021	SELL	$4.39 - $9.08 $1.77 Million - $3.66 Million	-402,884 Reduced 82.06%	88,078 $639,000
Q4 2020 Feb 12, 2021	SELL	$3.86 - $5.07 $4.48 Million - $5.88 Million	-1,159,893 Reduced 70.26%	490,962 $2.12 Million
Q3 2020 Nov 16, 2020	SELL	$4.11 - $6.45 $2.09 Million - $3.29 Million	-509,398 Reduced 23.58%	1,650,855 $6.79 Million
Q2 2020 Aug 14, 2020	SELL	$5.75 - $11.99 $1.2 Million - $2.5 Million	-208,517 Reduced 8.8%	2,160,253 $13 Million
Q1 2020 May 14, 2020	SELL	$5.65 - $15.71 $4.8 Million - $13.4 Million	-850,285 Reduced 26.41%	2,368,770 $17.8 Million
Q4 2019 Feb 11, 2020	BUY	$10.15 - $15.58 $32.7 Million - $50.2 Million	3,219,055 New	3,219,055 $44.3 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.